Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedang Murthy

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Clinical and Translational Radiation Oncology|December 24, 2025
Pre-PROTO-PRIME: stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer - feasibility, acute toxicity and dosimetric insightsSrinivas Chilukuri, Sham C Sundar, Vasanthapriya Subramani, et al.
Ecancermedicalscience|January 21, 2026
Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinentAditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder CancerVedang Murthy, Priyamvada Maitre, Mahendra Pal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomesSarbani Ghosh Laskar, Shwetabh Sinha, Prathamesh Pai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2026
International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative RadiotherapyAneesh Dhar, Shankar Siva, Vivian S Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Sadhana Kannan, et al.
BJC Reports|July 29, 2025
Long-term outcomes of consecutive patients of oropharyngeal cancer treated with radical radiotherapyAshwini Budrukkar, Sheetal R Kashid, Monali Swain, et al.
South Asian Journal of Cancer|October 5, 2017
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendationsVedang Murthy, Adnan Calcuttawala, Kirti Chadha, et al.
Head & Neck|December 16, 2015
Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urineManju Sengar, Siddhesh Chorghe, Kamini Jadhav, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Clinical and Translational Radiation Oncology|December 24, 2025
Pre-PROTO-PRIME: stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer - feasibility, acute toxicity and dosimetric insightsSrinivas Chilukuri, Sham C Sundar, Vasanthapriya Subramani, et al.
Ecancermedicalscience|January 21, 2026
Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinentAditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder CancerVedang Murthy, Priyamvada Maitre, Mahendra Pal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomesSarbani Ghosh Laskar, Shwetabh Sinha, Prathamesh Pai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2026
International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative RadiotherapyAneesh Dhar, Shankar Siva, Vivian S Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Sadhana Kannan, et al.
BJC Reports|July 29, 2025
Long-term outcomes of consecutive patients of oropharyngeal cancer treated with radical radiotherapyAshwini Budrukkar, Sheetal R Kashid, Monali Swain, et al.
South Asian Journal of Cancer|October 5, 2017
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendationsVedang Murthy, Adnan Calcuttawala, Kirti Chadha, et al.
Head & Neck|December 16, 2015
Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urineManju Sengar, Siddhesh Chorghe, Kamini Jadhav, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
Pageof 23